CT
Crispr Therapeutics
Resolving
Resolving brand mentions across new media
Crispr Therapeutics
Resolving brand mentions across new media
Crispr Therapeutics
Arcmira media summary
Browse CRISPR Therapeutics interviews, podcasts & event videos — 12 indexed from Bloomberg Podcasts & Future Proof, updated Mar 2026.
Biotech company curing diseases like Sickle Cell through gene editing.
Biotech company mentioned as a top holding in Ark's innovation ETF.
Biotechnology company mentioned as a top holding in Wood's flagship fund.
Biotech company mentioned as a top holding in Ark's flagship fund.
Arcmira tracks 12 indexed media appearances or mentions for CRISPR Therapeutics, tied to source videos, channels, and transcript-derived context.
Arcmira uses indexed YouTube videos and transcripts. Representative source evidence on this page includes "A Fireside with Cathie Wood: Innovation, Risk, and What Comes Next" with transcript-derived context and links when available.
CRISPR Therapeutics is connected to Sickle Cell Disease, Humanoid robots, Autonomous Vehicles in Arcmira's media graph.
12
Mentions
6.8M
Views
The trendline is visible, but the dated evidence behind CRISPR Therapeutics is in the premium layer.
“Biotech company curing diseases like Sickle Cell through gene editing.”
“Biotech company mentioned as a top holding in Ark's innovation ETF.”
“Biotechnology company mentioned as a top holding in Wood's flagship fund.”
“Biotech company mentioned as a top holding in Ark's flagship fund.”